210 related articles for article (PubMed ID: 25844926)
1. Developmental regulation and induction of cytochrome P450 2W1, an enzyme expressed in colon tumors.
Choong E; Guo J; Persson A; Virding S; Johansson I; Mkrtchian S; Ingelman-Sundberg M
PLoS One; 2015; 10(4):e0122820. PubMed ID: 25844926
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer-specific cytochrome P450 2W1: intracellular localization, glycosylation, and catalytic activity.
Gomez A; Nekvindova J; Travica S; Lee MY; Johansson I; Edler D; Mkrtchian S; Ingelman-Sundberg M
Mol Pharmacol; 2010 Dec; 78(6):1004-11. PubMed ID: 20805301
[TBL] [Abstract][Full Text] [Related]
3. Colon cancer-specific cytochrome P450 2W1 converts duocarmycin analogues into potent tumor cytotoxins.
Travica S; Pors K; Loadman PM; Shnyder SD; Johansson I; Alandas MN; Sheldrake HM; Mkrtchian S; Patterson LH; Ingelman-Sundberg M
Clin Cancer Res; 2013 Jun; 19(11):2952-61. PubMed ID: 23589180
[TBL] [Abstract][Full Text] [Related]
4. The CYP2W1 enzyme: regulation, properties and activation of prodrugs.
Guo J; Johansson I; Mkrtchian S; Ingelman-Sundberg M
Drug Metab Rev; 2016 Aug; 48(3):369-78. PubMed ID: 27257736
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 Binding and Bioactivation of Tumor-Targeted Duocarmycin Agents.
Bart AG; Morais G; Vangala VR; Loadman PM; Pors K; Scott EE
Drug Metab Dispos; 2022 Jan; 50(1):49-57. PubMed ID: 34607808
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 2W1 (CYP2W1) - ready for use as the biomarker and drug target for cancer?
Pan Y; Ong EC
Xenobiotica; 2017 Oct; 47(10):923-932. PubMed ID: 27690753
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 2W1 (CYP2W1) in Colorectal Cancers.
Chung FF; Mai CW; Ng PY; Leong CO
Curr Cancer Drug Targets; 2016; 16(1):71-8. PubMed ID: 26563883
[TBL] [Abstract][Full Text] [Related]
8. Expression of CYP2W1 in colon tumors: regulation by gene methylation.
Gomez A; Karlgren M; Edler D; Bernal ML; Mkrtchian S; Ingelman-Sundberg M
Pharmacogenomics; 2007 Oct; 8(10):1315-25. PubMed ID: 17979506
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1.
Karlgren M; Gomez A; Stark K; Svärd J; Rodriguez-Antona C; Oliw E; Bernal ML; Ramón y Cajal S; Johansson I; Ingelman-Sundberg M
Biochem Biophys Res Commun; 2006 Mar; 341(2):451-8. PubMed ID: 16426568
[TBL] [Abstract][Full Text] [Related]
10. Human Cytochrome P450 2W1 Is Not Expressed in Adrenal Cortex and Is Only Rarely Expressed in Adrenocortical Carcinomas.
Nolé P; Duijndam B; Stenman A; Juhlin CC; Kozyra M; Larsson C; Ingelman-Sundberg M; Johansson I
PLoS One; 2016; 11(9):e0162379. PubMed ID: 27598485
[TBL] [Abstract][Full Text] [Related]
11. CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW-610, NSC 721648) sensitivity in breast and colorectal cancer cells.
Tan BS; Tiong KH; Muruhadas A; Randhawa N; Choo HL; Bradshaw TD; Stevens MF; Leong CO
Mol Cancer Ther; 2011 Oct; 10(10):1982-92. PubMed ID: 21831963
[TBL] [Abstract][Full Text] [Related]
12. CYP2W1 polymorphism: functional aspects and relation to risk for colorectal cancer.
Stenstedt K; Travica S; Guo J; Barragan I; Pors K; Patterson L; Edler D; Mkrtchian S; Johansson I; Ingelman-Sundberg M
Pharmacogenomics; 2013 Oct; 14(13):1615-22. PubMed ID: 24088132
[TBL] [Abstract][Full Text] [Related]
13. Tumour-specific expression of CYP2W1: its potential as a drug target in cancer therapy.
Karlgren M; Ingelman-Sundberg M
Expert Opin Ther Targets; 2007 Jan; 11(1):61-7. PubMed ID: 17150034
[TBL] [Abstract][Full Text] [Related]
14. The expression of CYP2W1: a prognostic marker in colon cancer.
Stenstedt K; Hallstrom M; Johansson I; Ingelman-Sundberg M; Ragnhammar P; Edler D
Anticancer Res; 2012 Sep; 32(9):3869-74. PubMed ID: 22993331
[TBL] [Abstract][Full Text] [Related]
15. The expression of CYP2W1 in colorectal primary tumors, corresponding lymph node metastases and liver metastases.
Stenstedt K; Hallstrom M; Lédel F; Ragnhammar P; Ingelman-Sundberg M; Johansson I; Edler D
Acta Oncol; 2014 Jul; 53(7):885-91. PubMed ID: 24625228
[TBL] [Abstract][Full Text] [Related]
16. CYP2W1 is highly expressed in adrenal glands and is positively associated with the response to mitotane in adrenocortical carcinoma.
Ronchi CL; Sbiera S; Volante M; Steinhauer S; Scott-Wild V; Altieri B; Kroiss M; Bala M; Papotti M; Deutschbein T; Terzolo M; Fassnacht M; Allolio B
PLoS One; 2014; 9(8):e105855. PubMed ID: 25144458
[TBL] [Abstract][Full Text] [Related]
17. The expression of the novel CYP2W1 enzyme is an independent prognostic factor in colorectal cancer - a pilot study.
Edler D; Stenstedt K; Ohrling K; Hallström M; Karlgren M; Ingelman-Sundberg M; Ragnhammar P
Eur J Cancer; 2009 Mar; 45(4):705-12. PubMed ID: 19118998
[TBL] [Abstract][Full Text] [Related]
18. Molecular modeling of human cytochrome P450 2W1 and its interactions with substrates.
Li W; Tang Y; Hoshino T; Neya S
J Mol Graph Model; 2009 Sep; 28(2):170-6. PubMed ID: 19596602
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 isoforms 1A1, 1B1 AND 2W1 as targets for therapeutic intervention in head and neck cancer.
Presa D; Khurram SA; Zubir AZA; Smarakan S; Cooper PA; Morais GR; Sadiq M; Sutherland M; Loadman PM; McCaul J; Shnyder SD; Patterson LH; Pors K
Sci Rep; 2021 Sep; 11(1):18930. PubMed ID: 34556703
[TBL] [Abstract][Full Text] [Related]
20. Membrane topology and search for potential redox partners of colon cancer-specific cytochrome P450 2W1.
Guo J; Thiess S; Johansson I; Mkrtchian S; Ingelman-Sundberg M
FEBS Lett; 2016 Feb; 590(3):330-9. PubMed ID: 26787547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]